"It's good, but it's tedious..."
In the video below, Amir from San Francisco discusses his participation in the iPrEx Open Label Study and taking Truvada as a way to prevent HIV infection.
The iPrEx trial was the first study to show that an antiretroviral drug (ARV) - normally used to treat people living with HIV - could also be used to prevent HIV among people who are HIV-negative.
In July of 2012, the FDA approved the ARV drug Truvada for the prevention of HIV.
No comments:
Post a Comment